Abiopharma

🔍 Squadron Capital LLC (Executive)

Company: ORTHOPEDIATRICS CORP (KIDS)

Report Date: 2026-08-28

Detailed Transactions and Holdings:

• Sold 326,700 shares of Common Stock at $23.04 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 6,536,764.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 10,131 shares of Common Stock at $23.1 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 6,526,633.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3

Footnotes:

• F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.